Finance

Beta
Lists
BIOBV:HEL
Biohit Oyj
€2.76
+2.99%
(+0.080) 1D
Jun 5, 6:29:43 PM GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BIOBV...
Open
€2.56
High
€2.81
Low
€2.56
Mkt. cap
33.76M
Avg. vol.
9.53K
Volume
22.52K
52-wk high
€3.78
52-wk low
€2.20
Shares outstanding
12.23M
No. of employees
46
Open
€2.56
High
€2.81
Low
€2.56
Mkt. cap
33.76M
Avg. vol.
9.53K
Volume
22.52K
52-wk high
€3.78
52-wk low
€2.20
Shares outstanding
12.23M
No. of employees
46
News stories
From sources across the web
Profile
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
About Biohit Oyj
CEOJussi Hahtela
Employees46
Founded1988
Headquarters-
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.70M
3.70M
4.17M
4.17M
Cost of goods sold
1.25M
1.25M
1.24M
1.24M
Cost of revenue
1.25M
1.25M
1.24M
1.24M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.00M
1.00M
1.12M
1.12M
Operating expense
1.85M
1.85M
2.00M
2.00M
Total operating expenses
3.10M
3.10M
3.24M
3.24M
Operating income
600.00K
600.00K
926.00K
926.00K
Other non operating income
-50.00K
-50.00K
44.50K
44.50K
EBT including unusual items
550.00K
550.00K
900.50K
900.50K
EBT excluding unusual items
550.00K
550.00K
943.50K
943.50K
Income tax expense
100.00K
100.00K
-18.50K
-18.50K
Effective tax rate
18.18%
18.18%
-2.05%
-2.05%
Other operating expenses
750.00K
750.00K
692.00K
692.00K
Net income
450.00K
450.00K
919.00K
919.00K
Net profit margin
12.16%
12.16%
22.06%
22.06%
Earnings per share
-
-
-
-
Interest and investment income
50.00K
50.00K
27.50K
27.50K
Interest expense
-50.00K
-50.00K
-18.50K
-18.50K
Net interest expenses
-
-
9.00K
9.00K
Depreciation and amortization charges
100.00K
100.00K
107.00K
107.00K
EBITDA
700.00K
700.00K
1.08M
1.08M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more